A Measure of the Signal-to-Noise Ratio of Microarray Samples and Studies Using Gene Correlations

Por Venet, David, Detours, Vincent, Bersini, Hugues
Publicado em 2012

Most Random Gene Expression Signatures Are Significantly Associated with Breast Cancer Outcome

Por Venet, David, Dumont, Jacques E., Detours, Vincent
Publicado em 2011

Small amplified RNA-SAGE: an alternative approach to study transcriptome from limiting amount of mRNA

Por Vilain, Catheline, Libert, Frederick, Venet, David, Costagliola, Sabine, Vassart, Gilbert
Publicado em 2003

pAKT pathway activation is associated with PIK3CA mutations and good prognosis in luminal breast cancer in contrast to p-mTOR pathway activation

Por Sonnenblick, Amir, Venet, David, Brohée, Sylvain, Pondé, Noam, Sotiriou, Christos
Publicado no NPJ Breast Cancer (2019)

Imprint of parity and age at first pregnancy on the genomic landscape of subsequent breast cancer

Por Nguyen, Bastien, Venet, David, Lambertini, Matteo, Desmedt, Christine, Salgado, Roberto, Horlings, Hugo Mark, Rothé, Françoise, Sotiriou, Christos
Publicado no Breast Cancer Res (2019)

Unraveling Triple-Negative Breast Cancer Tumor Microenvironment Heterogeneity: Towards an Optimized Treatment Approach

Por Bareche, Yacine, Buisseret, Laurence, Gruosso, Tina, Girard, Edwina, Venet, David, Dupont, Floriane, Desmedt, Christine, Larsimont, Denis, Park, Morag, Rothé, Françoise, Stagg, John, Sotiriou, Christos
Publicado no J Natl Cancer Inst (2019)

Gene expression in human thyrocytes and autonomous adenomas reveals suppression of negative feedbacks in tumorigenesis

Por van Staveren, Wilma C. G., Solís, David Weiss, Delys, Laurent, Venet, David, Cappello, Matteo, Andry, Guy, Dumont, Jacques E., Libert, Frédérick, Detours, Vincent, Maenhaut, Carine
Publicado em 2006

Breast cancer diagnosed during pregnancy is associated with enrichment of non-silent mutations, mismatch repair deficiency signature and mucin mutations

Por Nguyen, Bastien, Venet, David, Azim, Hatem A., Brown, David, Desmedt, Christine, Lambertini, Matteo, Majjaj, Samira, Pruneri, Giancarlo, Peccatori, Fedro, Piccart, Martine, Rothé, Françoise, Sotiriou, Christos
Publicado no NPJ Breast Cancer (2018)

InSilico DB genomic datasets hub: an efficient starting point for analyzing genome-wide studies in GenePattern, Integrative Genomics Viewer, and R/Bioconductor

Por Coletta, Alain, Molter, Colin, Duqué, Robin, Steenhoff, David, Taminau, Jonatan, de Schaetzen, Virginie, Meganck, Stijn, Lazar, Cosmin, Venet, David, Detours, Vincent, Nowé, Ann, Bersini, Hugues, Weiss Solís, David Y
Publicado em 2012

Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcome

Por Venet, David, Fimereli, Danai, Rothé, Françoise, Boeckx, Bram, Maetens, Marion, Majjaj, Samira, Rouas, Ghizlane, Capra, Maria, Bonizzi, Giuseppina, Contaldo, Federica, Galant, Christine, Piccart, Martine, Pruneri, Giancarlo, Larsimont, Denis, Lambrechts, Diether, Desmedt, Christine, Sotiriou, Christos
Publicado no EBioMedicine (2020)

Constitutive phosphorylated STAT3-associated gene signature is predictive for trastuzumab resistance in primary HER2-positive breast cancer

Por Sonnenblick, Amir, Brohée, Sylvain, Fumagalli, Debora, Vincent, Delphine, Venet, David, Ignatiadis, Michail, Salgado, Roberto, Van den Eynden, Gert, Rothé, Françoise, Desmedt, Christine, Neven, Patrick, Loibl, Sibylle, Denkert, Carsten, Joensuu, Heikki, Loi, Sherene, Sirtaine, Nicolas, Kellokumpu-Lehtinen, Pirkko-Liisa, Piccart, Martine, Sotiriou, Christos
Publicado no BMC Med (2015)

Tumor-Infiltrating Lymphocytes in Patients Receiving Trastuzumab/Pertuzumab-Based Chemotherapy: A TRYPHAENA Substudy

Por Ignatiadis, Michail, Van den Eynden, Gert, Roberto, Salgado, Fornili, Marco, Bareche, Yacine, Desmedt, Christine, Rothé, Françoise, Maetens, Marion, Venet, David, Holgado, Esther, McNally, Virginia, Kiermaier, Astrid, Savage, Heidi M, Wilson, Timothy R, Cortes, Javier, Schneeweiss, Andreas, Willard-Gallo, Karen, Biganzoli, Elia, Sotiriou, Christos
Publicado no J Natl Cancer Inst (2018)

RNA Sequencing to Predict Response to Neoadjuvant Anti-HER2 Therapy: A Secondary Analysis of the NeoALTTO Randomized Clinical Trial

Por Fumagalli, Debora, Venet, David, Ignatiadis, Michail, Azim, Hatem A., Maetens, Marion, Rothé, Françoise, Salgado, Roberto, Bradbury, Ian, Pusztai, Lajos, Harbeck, Nadia, Gomez, Henry, Chang, Tsai-Wang, Coccia-Portugal, Maria Antonia, Di Cosimo, Serena, de Azambuja, Evandro, de la Peña, Lorena, Nuciforo, Paolo, Brase, Jan C., Huober, Jens, Baselga, José, Piccart, Martine, Loi, Sherene, Sotiriou, Christos
Publicado no JAMA Oncol (2017)

HER2-overexpressing breast cancers amplify FGFR signaling upon acquisition of resistance to dual therapeutic blockade of HER2

Por Hanker, Ariella B., Garrett, Joan T., Estrada, Mónica Valeria, Moore, Preston D., Ericsson, Paula González, Koch, James P., Langley, Emma, Singh, Sharat, Kim, Phillip S., Frampton, Garrett M., Sanford, Eric, Owens, Philip, Becker, Jennifer, Groseclose, M. Reid, Castellino, Stephen, Joensuu, Heikki, Huober, Jens, Brase, Jan C., Majjaj, Samira, Brohée, Sylvain, Venet, David, Brown, David, Baselga, José, Piccart, Martine, Sotiriou, Christos, Arteaga, Carlos L.
Publicado no Clin Cancer Res (2017)